Ucenprubart is an agonistic antibody to CD200R with the potential to treat inflammatory skin disease: preclinical development and a phase 1 clinical study
| Title: | Ucenprubart is an agonistic antibody to CD200R with the potential to treat inflammatory skin disease: preclinical development and a phase 1 clinical study |
|---|---|
| Authors: | Koester, AnjaAff1, IDs4146702559147w_cor1; Witcher, Derrick R.Aff2; Lee, MarkAff3; Demarest, Stephen J.Aff4, Aff6; Potter, ScottAff1; Werle, KatieAff1, Aff7; Bauer, ScottAff2; Ruiz, DianaAff4; Malherbe, LaurentAff5; Poorbaugh, JoshAff2; Glasebrook, AndrewAff1, Aff8; Preuss, ChristophAff2; Datta, GourabAff2; Wang, ZiqiaoAff2, Aff9; Knorr, JackAff2; Manner, DavidAff2; Patel, DipakAff1; Schmitz, CarstenAff1; Klekotka, PaulAff1; Nirula, AjayAff1, Aff10 |
| Source: | Nature Communications. 16(1) |
| Database: | Springer Nature Journals |